About the Author: Kim Rockley
Kim Rockley, PhD. Kim holds a PhD in Pharmacy from Durham University where she studied anthracycline-induced cardiotoxicity and its mitigation by in vitro. Before this, Kim gained with a BSc in Biomedical Science and a Master’s degree in Cancer Pharmacology from the University of Bradford, graduating with distinction. She also has experience as a Clinical Trial Coordinator at the Haematology and Oncology Centre, University Hospitals Bristol NHS foundation Trust. Kim is a creative research scientist who enjoys the busy and dynamic environment of ApconiX.